National survey of the management of Diabetic Ketoacidosis (DKA) in the UK in 2014 by Dhatariya, K K et al.
1 
 
Title: 
A national survey of the management of diabetic ketoacidosis in the UK in 
2014 
 
Authors: 
KK Dhatariya 1 
I Nunney 2 
K Higgins 3 
MJ Sampson 1 
Gillian Iceton 4  
 
1. Elsie Bertram Diabetes Centre, Norfolk and Norwich University 
Hospitals NHS Foundation Trust, Norwich, UK 
2. Norwich Medical School, University of East Anglia, Norwich, UK 
3. University Hospitals of Leicester NHS Trust, Leicester, UK 
4. Clinical Audit and Improvement Department, Norfolk and Norwich 
University Hospitals NHS Foundation Trust, Norwich, UK  
 
 
Corresponding author:  
Dr Ketan Dhatariya 
Consultant in Diabetes and Endocrinology. 
Elsie Bertram Diabetes Centre,  
Norfolk and Norwich University Hospitals NHS Foundation Trust,  
Colney Lane, 
Norwich, Norfolk, UK 
NR4 7UY 
 
Tel: +44 (0)1603 288170 
Fax: +44 (0)1603 287320 
Email: ketan.dhatariya@nnuh.nhs.uk 
 
Short title: A national survey of DKA management in the UK in 2014 
 
Word Count: Abstract – 250 Main Manuscript – 3997 
 
Funding:  All of the authors are employees of the UK National Health Service 
 
Duality of Interest The authors declare that there is no duality of interest 
associated with this manuscript. 
 
Keywords: Diabetic ketoacidosis; management; survey 
  
2 
 
Novelty Statement 
 
a) In 2013 a revised version of national guidance on the management of DKA 
was published, however there are no data to show that these 
recommendations actually work 
b) This is the largest national survey on the management of DKA 
c) Most patients developed hypokalaemia and over 25% developed 
hypoglycaemia. There were also significant issues with care processes 
d) The management of DKA will need to change to prevent hypokalaemia but 
will necessitate a shift in where patients are cared for. However, as a result of 
moving to a High Dependency or Intensive Care environment, care processes 
may improve.  
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Abstract 
 
Aims 
Outcomes for the management of diabetic ketoacidosis (DKA) remain largely 
unstudied. In a national survey we examined outcomes of adult patients 
presenting with DKA in 2014, mapped against accepted UK national 
guidance. 
Methods 
Data were collected in a standardised form covering clinical, and biochemical, 
outcome, risk, and discharge planning. The form was sent to all UK diabetes 
specialist teams (n=220). Anonymised data were collected on 5 consecutive 
patients admitted with DKA between 1.5.14 and 30.11.14  
Results 
 283 forms were received (n=281 patients), from 72 hospitals, 71.4% used the 
national guidelines. 7.8% of cases occurred in existing inpatients. 6.1% of 
admissions were newly diagnosed diabetes. 33.7% of patients had had at 
least 1 episode of DKA in the preceding year. The median time to starting 
0.9% sodium chloride and intravenous insulin was 41.5 minutes and 60 
minutes respectively. Median time to resolution was 18.7 hours, and median 
length of hospital stay was 2.6 days. Significant adverse biochemical 
outcomes occurred; with 27.6% of patients developing hypoglycaemia and 
55% reported hypokalaemia. There were also significant issues with care 
processes.  
 
Initial nurse led observations were well carried out, but subsequent patient 
monitoring remained suboptimal. Most patients were not seen by a member of 
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the diabetes specialist team during the first 6 hours, but 95% were seen 
before discharge.  
 
A significant minority of discharge letters to primary care did not contain 
necessary information.  
 
Conclusion 
 
Despite widespread adoption of national guidance, several areas of DKA 
management are suboptimal, being associated with avoidable biochemical 
and clinical risk.   
 
 
Keywords 
Diabetic ketoacidosis; Management; Guideline; National; Survey 
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Introduction 
Diabetic ketoacidosis (DKA) is a common and significant contributor to 
mortality and morbidity in people with type 1 diabetes [1]. It is a common 
experience among clinicians that much of the in hospital morbidity 
experienced by patients is related to DKA treatment, and that there is wide 
variability in the definition of DKA and use of guidelines between teams.  To 
date, there has only been one study that looked in detail at DKA outcomes 
that mapped outcomes against a standardised guideline [2].  
 
In 2010 the UK Joint British Diabetes Societies for Inpatient Care (JBDS-IP) 
published national guidance on the management of DKA, and revised these in 
2013 [3,4]. These guidelines have achieved high levels of adoption in the UK 
and suggest a formal diagnosis be based on a pH of <7.3, a blood glucose 
level of >11.0 mmol/L or a previous diagnosis of diabetes, and a blood ketone 
level of >3.0 mmol/L. The guidelines emphasised the importance of 
normalisation of ketone levels, using bedside ketone monitors to aid 
treatment, and a weight based, fixed rate intravenous insulin infusion (FRIII) in 
the initial management until the DKA had resolved. Fluid and potassium 
replacement guidance was also given. Several small scale audits within 
individual diabetes and acute medicine departments had been presented in 
regional and national meetings as abstracts, suggesting there was 
enthusiasm to assess the management of DKA nationally.  
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To address gaps in our understanding of modern DKA outcomes, we 
conducted a national survey on the management of DKA against the 
standards in the nationally adopted JBDS guidelines [4].  
 
Patients and Methods 
A data collection questionnaire was developed using the 2013 JBDS guideline 
as a template [See online materials - Appendix 1]. This questionnaire was 
sent out by email to all 220 UK specialist diabetes teams.  
 
We accessed the databases of Diabetes UK, the Association of British 
Diabetologists (ABCD), and the Diabetes Inpatient Specialist Nurse (DISN) 
UK Group. This was the network that was also used to conduct the 2012 
survey. 
 
One clinician from each Trust was asked to fill in and return a single form for 
each of the subsequent 5 patients admitted to their institution between May 
and November 2014 with a diagnosis of DKA. This number was chosen to try 
to gain as much meaningful information from individual units, without 
burdening them. 
 
Data were analysed using SPSS software (IBM Ltd, Portsmouth, UK). 
  
The Clinical Audit and Improvement Department of the Norfolk and Norwich 
University Hospitals NHS Foundation Trust deemed this survey a service 
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improvement exercise and that the project did not require multi-site ethical, 
research governance or audit approval.   
 
Results: 
Clinical details (Table 1) 
283 forms were received from 72 hospitals. 281 individual patient forms were 
received, with 2 patients having 2 admissions each. The participating 
hospitals are listed in Appendix 2. The demographics of the patients and 
where they received treatment are shown (Table 1).  
 
Admissions for DKA were least frequent between 8pm and 7am, with only 
29.4% of admissions during the night, but the remainder were spread equally 
throughout the rest of the day. There were no differences in the pH or 
bicarbonate levels in those admitted during the night compared to those 
admitted during the day. The median length of stay for the whole cohort was 
2.6 days (IQR 1.5, 4.8) with a mean of 4.2 days (SD 5.6). 7.8% of all episodes 
had developed in existing in-patients, and 33.7% of patients had had at least 
1 previous admission for DKA in the preceding 12 months (median 2, range 1 
- 100).  
 
Management in the first hour (Table 2) 
 
The diagnosis of DKA was made a median of 35.5 minutes (IQR 18, 81) after 
initial presentation to the emergency room. 0.9% sodium chloride solution was 
first started a median of 41.5 minutes (IQR 21, 90), and the median time for 
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the fixed rate intravenous insulin infusion being started was 60 minutes (IQR 
29, 105). Table 2 shows issues surrounding the diagnosis and management 
of the patients during the first hour after admission. Senior review occurred 
immediately in 34.3%, and after the initial management, in a further 50.9%. 
No senior review was carried out in 2.1%.  
 
Biochemical changes in first 24 hours (Figures 1a – 1c) 
 
Admission mean pH (±SD) was 7.16 (±0.15), the mean glucose was 28.7 
mmol/l (±10.9), mean blood ketone concentration was 5.68 mmol/l (±1.5), and 
mean bicarbonate was 11.3 mmol/l (±5.1). The mean potassium on admission 
was 4.8 mmol/l (±1.0). Figures 1a, 1b and 1c show the changes in pH, 
bicarbonate and potassium values during the course of the 24 hours following 
admission. In 55.1% of cases, the potassium levels were outside the range of 
4.0 – 5.5 mmol/l. As figure 1c shows, mean potassium dropped, with 18.6% 
and 67.1% of patients having a potassium concentration less than 4.0mmol/l 
at 1 hour and 24 hours respectively. The mean lowest recorded potassium 
during the admission was reported as 3.65 mmol/l (±0.66), suggesting that the 
majority of the out-of-range potassium was due to hypokalaemia. 
 
The mean lowest recorded glucose was 4.7 mmol/l (±2.3), with 27.6% of 
patients developed overt hypoglycaemia. The median time to developing 
hypoglycaemia was 14.7 hours (IQR 10.5, 25.0) after admission. 29.6% of 
patients in whom the long acting insulin was not continued developed 
hypoglycaemia, with 36.6% developing hypoglycaemia if it was continued.  
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Adherence to guidelines (Table 3) 
 
The results showing the continued management of the patients during and 
after the first hour and up to 24 hours are shown in Table 3. 20.1% of 
respondents felt that potassium replacement was not done in accordance with 
their guidelines. In addition, 0.9% sodium chloride solution and a fixed rate 
intravenous insulin infusion were also not used according to local protocols in 
9.9% and 7.8% respectively. There was no statistical difference between 
glucose or potassium levels between those who reported following the 
guidelines and those who did not. 
 
Resolution and on-going in-hospital management (Table 4) 
 
The median length of time to resolution of DKA was 18.7 hours (IQR 11.3, 
27.8). This is in contrast to previous data that suggested that resolution was 
achieved in 12.1 hours [2]. Whilst 83.1% of teams said that the resolution of 
DKA had been confirmed, only 11% of respondents said they used pH to 
diagnose resolution, 17.3% used ketone measurement, 95% used glucose 
and 5.3% used bicarbonate.  
 
Patients were discharged from hospital a median of 2.6 days after admission 
(IQR 1.5, 4.8).  
 
Discharge planning (Table 5) 
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Table 5 shows the steps involved prior to discharge.  
 
Discussion 
 
This large national survey - 30% of UK hospitals participated - has found that 
most have adopted or adapted the national guidelines produced by the Joint 
British Diabetes Societies for Inpatient Care group for the management of 
patients presenting with DKA [4]. Prior to the publication of the national 
guidance and this analysis, there was no way of knowing if the standards of 
care used to treat DKA were effective. Previous work has shown that the use 
of a standardised management protocol is associated with improved 
outcomes, in particular, reducing length of stay [5], but there are few data 
looking at modern national outcomes in DKA management  [6-8]. 
 
This survey was undertaken using the framework of this national guidance; 
we found that despite widespread adoption, the majority of patients develop 
hypokalaemia, and more than 27% developing hypoglycaemia during their 
treatment. These data do not show any differences between the risk of 
developing hypoglycaemia or hypokalaemia and whether the guideline for 
potassium replacement or the intravenous insulin regimen was used or not. 
However, given that there are no previous data on this scale, it is not known if 
there has been an improvement in overall standards of care since individual 
hospitals adopted or adapted the guideline.  What the current data suggest is 
several areas of management were well carried out – in particular ‘process 
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issues’ – carried out in the first few hours after presentation. These were most 
likely to be carried out by nursing staff in the emergence department. Tables 2 
to 5 show where practice was well carried out. However, these data also show 
that there is some room for continued improvement in many areas and that 
the guideline needs amending, to ensure more aggressive potassium 
replacement, and an adjustment of the intravenous insulin regimen. However, 
there remain significant shortfalls in management, in particular ‘process 
issues’ surrounding monitoring, e.g. capillary glucose or ketone 
measurements, urine output, etc., that need to be addressed. 
 
Morbidity and Mortality Associated with DKA 
 
There are few recent data on the incidence and prevalence of DKA, and in 
particular the morbidity and mortality caused by this condition. Data from the 
Centers for Disease Controls in the US reported that between 1988 and 2009 
the age adjusted discharge rate for DKA as the first listed diagnosis rose from 
3.2 to 4.6 per 10,000 population [9].  In England and Wales, the National 
Diabetes Audit in 2011/2012 data reported that there had been 7608 adults 
with at least 1 episode of DKA during that year, representing a crude 
prevalence of 3.57% [10].  
 
In this dataset there was 1 reported death, 33 days after admission with DKA 
that had resolved within 24 hours of admission, in a 72 year old man with a 
hospital acquired pneumonia and osteomyelitis. Mortality data from 
Birmingham, UK was reported to have decreased from 3.9% between 1971-
12 
 
1991 to 1.8% between 2000 and 2009 [11,12]. More recently, some authors 
have suggested that with improvements in overall care, deaths from 
hyperglycaemic crisis and DKA have been declining [13], but it remains a 
condition with a significant mortality in adults of between 0.7 and 5% 
[12,14,15].  
 
Our data show that 7.8% of patients had developed DKA during their inpatient 
stay. This is in marked contrast to the data from the National Diabetes 
Inpatient Audit, which suggested that only 0.4% of patients developed DKA 
who took part in that audit developed DKA during that admission [1]. The data 
collection strategy was different, and the patient population was different, but 
the large number is still striking. 32.8% had had at least 1 episode of DKA in 
the previous 12 months (range 1-100). The causes of inpatient DKA were not 
given in 4 cases, in 9 cases, patients had developed infections (urinary tract, 
gastroenteritis or dental), 2 patients developed vomiting (1 post-partum), in 6 
cases, there were insulin administration errors. That so many people 
developed DKA whilst a hospital inpatient is clearly of great concern. The 
failure to administer insulin correctly has been identified as a ‘Never Event’ by 
NHS England [16]. As a result of this data it would be prudent for hospitals to 
have mechanisms for every case of in hospital DKA to be investigated, and 
interventions put in place to prevent these from recurring.  
 
 
Management of DKA in the First Hour 
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10 people (3.5%) presented with blood glucose levels of 12mmol/l or less, 
suggesting that ‘euglycaemic ketoacidosis’ remains an important differential 
diagnosis. Furthermore, given that 14.8% of all patients required a ‘stat’ dose 
of insulin within the first hour after diagnosis, this suggests there may have 
been a delay in treatment in these individuals, even though the median time to 
starting fluids and insulin was 41.5 and 60 minutes respectively after initial 
presentation to the emergency room.  
 
That almost all patients were treated with 0.9% sodium chloride solution 
(‘normal saline’) suggests that most acute medical teams and diabetes 
specialist teams use this as the first line fluid of choice. This issue has 
previously been discussed elsewhere [17]. The data to show that alternative 
fluids are associated with better outcomes is lacking [18]. 
 
The move to a fixed rate intravenous insulin infusion (FRIII) has been very 
quickly taken up across the UK and is a clear change of practice since the 
introduction of the JBDS guideline. In addition, the use of venous blood gases 
analysis is now very frequent. This has been advocated because the 
perceived difference between arterial and venous bicarbonate is small enough 
to be clinically insignificant when making management decisions in DKA [19]. 
 
Nurse led initial observations were carried out in most cases. However, 
factors that may have more traditionally fallen to the doctors were less well 
done. Of note is that only 33.9% of patients had a record of their feet being 
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looked at, despite recommendations that the feet of all patients with diabetes 
admitted to hospital should be examined [20].  
 
80.9% of patients had their blood ketone levels measured. There has been an 
argument against the use of hand held, point of care ketone testing meters in 
hospital because of their potential inaccuracy and lack of well conducted 
clinical trials [21]. However to date, these fears do not seem to have resulted 
in any measurable patient harms and have become an integral part of the 
management of DKA [22].   
 
The lack of a chest X-ray in 1 in 4 and an ECG in 14% of admissions warrants 
further investigation. Potassium remains the most significant electrolyte 
disturbance in DKA. Due to both metabolic acidosis and osmotic diuresis, it 
has been estimated that even in ‘mild’ DKA, at the time of presentation, an 
individual may have a deficit of 3-5mmol/Kg [23]. Therefore adequate 
potassium replacement is paramount, but this has its problems due to 
potential of acute cardiac toxicity if given too fast. National guidelines suggest 
replacement regimens [4,23], but it is clear that these need to be altered, 
because most patients developed hypokalaemia. From the current database, 
there is no evidence of harm from the lowered levels of potassium. In addition, 
to replace potassium more aggressively may mean the insertion of a central 
venous catheter, and/or being cared for in a Level 2/3 (High 
Dependency/Intensive Care Unit) environment where a cardiac monitor is 
available. This shift would have potentially major consequences on resources, 
given that just 55% of patients are cared for in the acute medical unit, or a 
15 
 
Level 1 (general) medical ward where monitored beds are less likely to be 
available than on a high dependency or intensive care unit. This may cause 
more controversy, because a survey of 13 intensive care units across the 
East of England showed that most did not adhere to any form of national 
guidance [24]. 
 
The changes over time in, pH, bicarbonate and potassium are shown in 
Figures 1, 2 and 3 respectively. Potassium levels continued to drop as shown, 
despite 77.4% of teams saying that they followed their potassium replacement 
guidelines. Figure 1 shows how pH levels rise to 7.35 by just under 19 hours 
after admission, with Figure 2 showing the changes in bicarbonate levels, 
rising to greater than 15mmol/L by 6 hours.  
 
The most commonly identified precipitants were infection (44.6%), and non-
compliance (19.7%). Other causes included newly diagnosed diabetes in 
6.1% and alcohol/ drugs related (5.8%). In 18.7% of current cases, no 
precipitant was identified. This data is in contrast to recent work from the 
paediatric population who suggested that up to 25% of cases were due to 
newly diagnosed diabetes [25]. 
 
A quarter of patients did not have an appropriate monitoring regimen 
instituted. More than 1 in 7 patients did not have their capillary glucose 
measured hourly, despite being on an intravenous insulin infusion. This issue 
was also previously identified in the UK National Diabetes Inpatient Audit 
2013 [1]. In addition, even though DKA is a recognised medical emergency, 
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and patients are usually very ill, 26.9% did not have hourly observations 
taken, and over 1 in 5 did not have hourly assessment of urine output. It 
would seem that if an appropriate monitoring regimen was not in place, then it 
is unlikely that the potassium or glucose was also correctly managed. Thus 
the data reporting that monitoring frequency was inadequate are likely to be 
underestimates. 
 
Together, these failures in process issues and patient management after the 
initial assessments on admission may be a reflection in how busy nursing and 
medical staff are in the ward areas where patients with DKA are cared for 
(Table 1). Further work needs to be done to assess if this lack of appropriate 
monitoring leads to any patient harm.  
 
Hypoglycaemia 
 
Hypoglycaemia developed in 27.6% of all patients, at a median time of 14.7 
hours after treatment was started. It is possible that the currently used insulin 
infusion regimen is too aggressive when glucose levels drop, and it may be 
necessary to adjust the insulin infusion rate. Our data differs from that from 
Crasto et al who found that their median time to developing hypoglycaemia 
(just under 12.9 hours) was after their median time to resolution (12.1 hours), 
suggesting that the intravenous insulin infusion was used for too long [2]. In 
the present study, there was no relationship between developing 
hypoglycaemia and not getting 10% dextrose when the blood glucose 
dropped below 14mmol/l. These may be due to the relatively small numbers in 
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these groups.  That more than a third of patients developed hypoglycaemia 
whilst continuing with a long acting insulin is of concern. Previous work has 
shown that continuing the basal insulin is associated with a reduction in 
rebound hyperglycaemia [26]. Given the data to show that hypoglycaemia is a 
strong predictor for increased length of hospital stay and mortality [27,28], 
more work will need to be done to determine what the optimal approach 
should be.  
 
On-going Management in Hospital 
 
In two thirds of people, treatment and monitoring was reviewed by junior 
medical staff alone, with no further senior involvement being recorded. This is 
concerning because of the data showing that confidence amongst junior 
doctors in managing diabetes remains low [29]. Similarly, 53% of all DKA 
admissions did not involve the diabetes specialist team during the acute 
phase of the illness, despite the evidence that input from the diabetes team 
helps to reduce the length of hospital stay [30].  In addition, in the UK, 
diabetes specialist team involvement is integrated into recommendations from 
the National Institute for Clinical and Healthcare Excellence (NICE) [20]. 
 
Discharge and Follow-up 
 
Perhaps unsurprisingly, almost 83% of all admission did not receive 
psychological support prior to discharge. There are data to show that eating 
disorders are more common in this population and early identification and 
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intervention is likely to help further deterioration [31]. The provision of this 
service is known to be lacking in many teams although advocated by NICE as 
an important part of a diabetes team [32].  
 
In many cases, the discharge letter to the primary care team did not contain 
the correct name of the insulin, the right dose of insulin or the correct insulin 
delivery device. Discharge summaries are most often filled out by the most 
junior members of the medical team – doctors who are only 1 or 2 years post-
qualification. As mentioned, the data show that a large number of admissions 
had no contact with the diabetes specialist team, and with the previous work 
showing low confidence among junior staff when managing diabetes, it may 
well be that this combination led to these omissions [29].  
 
Further areas of concern highlighted were that over 30% of patients did not 
have any form of follow up by the diabetes specialist team within 30 days of 
discharge, and that communication with the primary care team was poor. In 
the UK, there is a recommendation that a written care plan be drawn up 
between the patient and the diabetes specialist team, and that a copy of the 
care plan be sent to the primary care team. However, this was not done in 
41.3% and 38.2% or cases respectively.  
 
Access to ketone testing on discharge was limited. More than 1 in 4 patients 
had no access to ketone testing on discharge, despite almost a third of 
patients having had a previous admission with DKA in the previous year. 
Previous work – albeit of low quality – has shown early identification of 
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ketonaemia and hyperglycaemia may allow for appropriate treatment to be 
started (even at home) if patients have hand held ketone monitors [33]. 
 
Limitations 
 
There are several limitations to our data. We asked for voluntary contributions 
from teams across the UK, and for sequential cases admitted to hospital but 
some case selection may have occurred. There may have been particular 
reason to choose patients who developed DKA as an inpatient to try and 
highlight poor practices in their place of work, or to submit data where the 
outcomes were deemed better than in most case. There is no way of knowing 
if such case selection took place, and the data are presented in the 
assumption that across the UK the data were done so in ‘good faith’. 
Furthermore, due to the nature of the data collection exercise, because the 
authors did not perform a direct review of the medical records, the authors 
were unable to verify the accuracy of the information submitted.  In addition, 
whilst individuals have said that they have adopted the guidelines it may be 
that the medical and nursing staff are not using it correctly.  
 
An important omission was the glucose data after admission. Hence we are 
unable to provide predictors for severity. We did not ask for a definition of 
hypoglycaemia (although this is widely accepted to be less than 4mmol/L) or 
the frequency of occurrence of hypoglycaemic episodes. In addition, only 72 
(out of a possible 220) hospitals returned any data. Despite this, we feel that 
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the forms returned are likely to be a reasonable representation of patients 
presenting daily to emergency teams across the UK and elsewhere. 
 
It is not known whether the areas where deficiencies have been highlighted 
(e.g. foot examination), was because it was not done or not recorded.  
 
Importantly, because of the nature of the survey, we collected no personal 
information on individual patients. Thus we have no way of linking to the UK 
National Diabetes Audit and so correlate the current data with frequency of 
previous admissions, hospital clinic attendance rates, previous HbA1c, 
socioeconomic data, or the presence of other co-morbidities. Previous work 
has shown that poor glycaemic control and frequent clinic non-attendance, 
female gender, the presence of psychological problems and comorbidities all 
increased the risk of DKA [12,34]. Other factors reported in the US included 
low household income, having a low education, and having no health 
insurance [34]. Linkage of local DKA data to nationwide databases is needed 
to allow investigators to look at predictors of DKA, and to calculate the 
prevalence, something were unable to do because we had no denominator.  
 
In summary we believe that these data represent the largest ever nationwide 
survey on the management of DKA. The data show that a large majority of 
Trusts have adopted the UK national guidelines and we show several novel 
and important findings including the low mortality, swift biochemical resolution, 
and the relatively low length of hospital stay. We also show no differences in 
outcomes between those who follow the national guidelines and those who do 
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not, although this conclusion may be limited to the small numbers. However, 
there remain important areas where further work is needed. In particular to 
determine whether the development of low potassium and glucose is due to 
the poor adherence to the current guideline or because the guideline is wrong. 
In addition, there remain a significant number of process issues that individual 
hospitals must address, which may include increased education for staff. 
Furthermore, there may be a small number of patients who are cared for by 
inexperienced, junior staff and who do not come into contact with more senior 
members of the medical team, or the diabetes specialist team. Patients may 
be discharged with the incorrect name and/or dose of insulin on the discharge 
letters. These issues highlight the need for Trusts to make education and 
training mandatory for all medical and nursing staff. Future work needs to 
include prospective randomised studies to assess the efficacy and safety of 
each part of the pathway. It is likely that these will require very large patient 
numbers due to the heterogeneity of the population. We feel that the 
existence of national guidelines in multiple sites in the UK allows the valuable 
process of audit against hard quantitative end points, and a cycle of 
improvement. To this end, each hospital that contributed data for this survey 
(listed in online appendix 2) will be sent their own results with a summary of 
the aggregated national results to aid self-improvement. 
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Table 1 – n=283 
 
Gender Male 51.9% Missing data 1.8% 
 Female 46.3%   
     
Mean age – 
years (±SD) 
 37.8 (±18.5)   
     
Ethnicity White  81.6% Missing data 14.5% 
 Mixed White/ 
Asian or 
White / Black 
Caribbean 
0.8%   
 Indian / Asian 1.4%   
 African / 
Black 
1.5%   
 Other 0.4%   
     
Treatment 
Area 
Level 1 
(General 
ward) 
15.9% Missing data 2.8% 
 Level 2 (High 
dependency) 
14.2%   
 Level 3 
(Intensive 
care) 
9.5%   
 Acute 
Medical Unit 
39.2%   
 Accident and 
Emergency 
10.2%   
 Combination 7.9%   
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Table 2 – n=283 
 
Variable Yes (%) No (%) Missing data (n (%)) 
Was the Diagnosis Made According to Local Criteria? 67.1 3.2 84 (29.7) 
Was the Diagnosis Made Using JBDS Criteria? 71.4 18.7 28 (9.9) 
Seen by ICU or a Senior? 85.9 7.1 19 (6.7) 
Was the Care Given in an Appropriate Area? 94 2.1 10 (3.5) 
Was a 'Stat' Insulin Dose Given? 14.8 84.1 3 (1.1) 
Was 0.9% Sodium Chloride Solution Used? 96.5 3.2 1 (0.4) 
Was an FRIII used? 91.5 8.5 0 (0) 
Potassium Replacement in Accordance with Local Protocol? 79.9 12.9 20 (7.2) 
Early Warning Score Recorded? 91.2 3.2 16 (5.7) 
Respiratory Rate Recorded? 96.5 0.4 9 (3.2) 
Temperature Recorded? 95.4 0 13 (4.6) 
Pulse Rate Recorded? 97.2 0 8 (2.8) 
Oxygen Saturations Recorded? 97.2 0 8 (2.8) 
Glasgow Come Scale Recorded? 89.8 6.7 10 (3.5) 
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Full History Recorded? 95.8 3.2 3 (1.1) 
Full Examination Recorded? 92.6 3.2 11 (3.9) 
Foot Examination Recorded? 33.9 47.7 52 (18.4) 
Blood Ketones Recorded? 80.9 15.9 9 (3.2) 
Capillary Blood Glucose Recorded? 97.5 0.7 5 (1.8) 
Venous Plasma Glucose Recorded? 93.3 4.2 7 (2.5) 
Urea and Electrolytes Recorded? 98.9 0 3 (1.1) 
Venous Blood Gases Recorded? 92.9 5.7 4 (1.4) 
Full Blood Count Performed? 92.2 3.2 13 (4.6) 
ECG Performed? 79.9 14.1 17 (6.0) 
CXR Performed? 69.3 23.7 20 (7.1) 
Urinalysis Performed? 74.9 13.1 34 (12) 
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Table 3 – n=283 
 
Variable Yes (%) No (%) Missing data (n (%)) 
Was IV 0.9% Sodium Chloride Solution Replacement Given as per 
Local Guidance? 
89.4 9.9 2 (0.7) 
Was Potassium Replaced as per Local Guidance? 77.4 20.1 7 (2.5) 
Did Potassium Levels Remain between 4.0 - 5.5 mmol/L? 43.1 55.1 5 (1.8) 
Was a FRIII used as per Local Guidance 90.5 7.8 5 (1.8) 
Was an Appropriate Monitoring Regimen Established? 70.3 25.1 13 (4.6) 
Capillary Glucose Levels Measured Hourly? 81.6 13.1 15 (5.3) 
Ketone Levels Measured Hourly? 57.6 37.1 15 (5.3) 
Observations of Vital Signs taken Hourly? 67.8 26.9 15 (5.3) 
EWS measured Hourly? 67.1 32.5 21 (7.4) 
Urine Output Documented? 74.2 22.6 9 (3.2) 
Was 10% Glucose started when the Glucose Dropped to <14mmol/l? 82.7 15.2 6 (2.1) 
Review of Fluid Balance with the Rate of Normal Saline Amended if 
Appropriate? 
68.9 20.8 29 (10.2) 
Was a Long Acting Insulin Continued? 58.3 38.5 8 (2.8) 
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Was there a Review of Metabolic Response to Treatment? 85.9 5.7 22 (7.8) 
If Yes, Were Appropriate Changes in Treatment Made? 58.7 10.2 86 (30.4) 
Did The Patient Ever Develop Hypoglycaemia? 27.6 67.5 14 (4.9) 
If Progress was not Satisfactory, Did a Senior Review Occur? 33.2 52.3 41 (14.5) 
Was a Precipitating Cause Found? 77.0 13.8 25 (8.8) 
Was a Referral to Diabetes Team Made? 92.6 4.2 9 (3.2) 
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Table 4 – n=283 
 
Variable Yes (%) No (%) Missing data (n (%)) 
Was Resolution of DKA Confirmed? 83.1 9.2 22 (7.8) 
Treatment and Monitoring Reviewed by SpR/Consultant on-call? 11.0 67.5 61 (21.6) 
Was the Specialist Diabetes Team Involved During the Acute Phase? 13.4 53.0 95 (33.6) 
Where Necessary, was a VRIII Used According to Local Policy? 50.9 43 17 (6.1) 
When Eating & Drinking and no Ketones, Were They Transferred to 
Subcutaneous Insulin? 
87.6 7.1 16 (5.7) 
Was This Transition to Subcutaneous Insulin Managed Appropriately? 83.4 12.4 12 (4.2) 
After DKA Resolution, Were They Reviewed by the DIST? 95.1 3.9 3 (1.1) 
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Table 5 – n=283 
 
Did the Patient Receive Education Support Before Discharge? 86.8 8.8 13 (4.6) 
Did the Patient Receive Psychological Support Before Discharge? 8.1 82.7 26 (9.2) 
Did the Discharge Letter Contain all the Correct Clinical Information? 91.2 2.5 17 (6.0) 
Did the Discharge Letter Contain the Correct Insulin Dose? 76.3 15.5 23 (8.1) 
Did the Discharge Letter Contain the Correct Delivery Device? 56.9 32.5 30 (10.6) 
Did the Discharge Letter Contain the Correct Insulin Name? 83.7 8.8 20 (7.1) 
Did Follow up by DIST Take Place Within 30 Days? 54.1 31.1 41 (14.5) 
Were there Any Post-Discharge Complications? 9.2 83.0 22 (7.8) 
Was There a Written Care Plan Between Patient and DIST? 46.6 41.3 34 (12.0) 
Was a Copy of the Care Plan sent to GP? 53.4 38.2 24 (8.5) 
Did the Patient have Access to Ketone Testing on Discharge? 55.5 26.1 52 (18.4) 
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Legends  
Table 1 
Baseline demographics of patients. 
Table 2 
Management of the patient in the first hour after diagnosis of DKA was made. 
The number and percentage of missing data for each variable is shown.  
JBDS – Joint British Diabetes Societies for Inpatient Care Group 
ICU – Intensive Care Unit 
FRIII – Fixed Rate Intravenous Insulin Infusion 
ECG – Electrocardiogram 
CXR – Chest X-Ray 
EWS – Early Warning Score 
Table 3 
Ongoing management between 1 and 24 hours after the diagnosis of DKA 
was made.  
VRIII – Variable Rate Intravenous Insulin Infusion 
Table 4 
Data showing the management of DKA beyond 24 hours, once the resolution 
of DKA had been confirmed. 
SpR – Specialist Registrar 
DIST – Diabetes Inpatient Specialist Team 
Table 5 
Data showing the management of DKA once resolution had been confirmed. 
DIST – Diabetes Inpatient Specialist Team 
GP – General Practitioner 
Figure 1a  
Changes in pH over time 
Figure 1b 
Changes in bicarbonate over time (mmol/l). The error bars are ±1SD 
Figure 1c 
Changes in potassium over time (mmol/l). The error bars are ±1SD 
Online Appendix 1 
Questionnaire sent to adult diabetes teams in all UK hospitals  
Online Appendix 2 
List of all contributing hospitals, contributors, and the numbers of forms they 
submitted 
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